Correlation Between Foghorn Therapeutics and Candel Therapeutics
Can any of the company-specific risk be diversified away by investing in both Foghorn Therapeutics and Candel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Foghorn Therapeutics and Candel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Foghorn Therapeutics and Candel Therapeutics, you can compare the effects of market volatilities on Foghorn Therapeutics and Candel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Foghorn Therapeutics with a short position of Candel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Foghorn Therapeutics and Candel Therapeutics.
Diversification Opportunities for Foghorn Therapeutics and Candel Therapeutics
-0.52 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Foghorn and Candel is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Foghorn Therapeutics and Candel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Candel Therapeutics and Foghorn Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Foghorn Therapeutics are associated (or correlated) with Candel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Candel Therapeutics has no effect on the direction of Foghorn Therapeutics i.e., Foghorn Therapeutics and Candel Therapeutics go up and down completely randomly.
Pair Corralation between Foghorn Therapeutics and Candel Therapeutics
Given the investment horizon of 90 days Foghorn Therapeutics is expected to under-perform the Candel Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Foghorn Therapeutics is 2.68 times less risky than Candel Therapeutics. The stock trades about -0.14 of its potential returns per unit of risk. The Candel Therapeutics is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 457.00 in Candel Therapeutics on December 2, 2024 and sell it today you would earn a total of 441.00 from holding Candel Therapeutics or generate 96.5% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Foghorn Therapeutics vs. Candel Therapeutics
Performance |
Timeline |
Foghorn Therapeutics |
Candel Therapeutics |
Foghorn Therapeutics and Candel Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Foghorn Therapeutics and Candel Therapeutics
The main advantage of trading using opposite Foghorn Therapeutics and Candel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Foghorn Therapeutics position performs unexpectedly, Candel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Candel Therapeutics will offset losses from the drop in Candel Therapeutics' long position.Foghorn Therapeutics vs. C4 Therapeutics | Foghorn Therapeutics vs. Prelude Therapeutics | Foghorn Therapeutics vs. Rezolute | Foghorn Therapeutics vs. Shattuck Labs |
Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |